Central Adiposity More Harmful Than Obesity in Older Women

This article originally appeared here.
Share this content:
Central Adiposity More Harmful Than Obesity in Older Women
Central Adiposity More Harmful Than Obesity in Older Women

FRIDAY, Feb. 24, 2017 (HealthDay News) -- Among women 70 to 79, being overweight or obese doesn't appear to shorten life span -- unless the weight is centered around the waist; however, being underweight does appear to shorten life span, according to a study published online Feb. 23 in the Journal of the American Geriatrics Society.

Zhao Chen, Ph.D., of the College of Public Health at the University of Arizona in Tucson, and colleagues reviewed data on 161,808 women aged 50 to 79 who took part in the Woman's Health Initiative. At the start of the study, the researchers measured the height, weight, and waist size of all the participants and recorded other lifestyle data.

During 11 years of follow-up, 18,320 women died. The researchers found being underweight was associated with higher mortality, but being overweight or slightly obese didn't affect life span. Class II or class III obesity increased the odds of early death by around 10 percent. Higher waist circumference was consistently tied to higher mortality rates during the study. The researchers also found that the risk of mortality increased when waist circumference measured more than 31.5 inches, and they classified anything above nearly 35 inches as an extreme risk. Hispanic women were somewhat protected -- they had lower mortality rates at any waist measurement or body mass index level than white or black women.

"Underweight is a significant risk factor for mortality in older women, and healthy body mass index ranges may need to be specific for age, race, and ethnicity," the authors write. "The findings support a consistent relationship between central obesity and mortality."

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Approves Ocrevus to Treat Severe Form of Multiple Sclerosis

FDA Approves Ocrevus to Treat Severe Form of ...

First drug sanctioned in United States for primary progressive multiple sclerosis

Study Explores Links Between Zika, GBS, Microcephaly in Brazil

Study Explores Links Between Zika, GBS, Microcephaly in ...

Apparent resurgence of Zika virus and GBS early in 2016, but no subsequent increase in microcephaly

Inadvertent HPV Vax Doesn't Up Risk of Poor Pregnancy Outcomes

Inadvertent HPV Vax Doesn't Up Risk of Poor ...

No increased risk of major birth defect, spontaneous abortion, preterm birth, low birth weight, SGA

is free, fast, and customized just for you!

Already a member?

Sign In Now »